Description
Doxofylline and Ambroxol Hydrochloride Tablets
Composition:
Each uncoated tablet contains :
Doxofylline IP 400 mg
Ambroxol Hydrochloride IP 30 mg
INDICATION & USE
• Asthma & Chronic inflammatory
• Airway Hyperesponsiveness
• Asthma & Chronic inflammatory
• Airway Hyperesponsiveness
Each uncoated tablet contains :
Doxofylline IP 400 mg
Ambroxol Hydrochloride IP 30 mg
• Asthma & Chronic inflammatory
• Airway Hyperesponsiveness
Shince Pharmaceuticals Pvt Ltd., a division of Surien Pharmaceuticals (P) Ltd., delivers excellence in pharmaceutical manufacturing and innovation worldwide.
Reviews
There are no reviews yet.